SEC Nets $18M From Drug Co. Accused Of Duping Investors

By Jessica Corso (March 25, 2015, 3:48 PM EDT) -- A Massachusetts-based life sciences company was ordered Wednesday to pay $17.9 million to the U.S. Securities and Exchange Commission in a lawsuit accusing the company of selling investors millions of dollars' worth of stock by falsely suggesting that its products would soon secure the necessary regulatory approvals....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!